Pagrindinis psl.>Klinikinis tyrimas>ERN-EYE narių ekspertizių centruose atliekami klinikiniai tyrimai pagal ligas.>RET IRD 02

How to use the speech recognition tool?

NCT01521793

RET IRD 02

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or
Retinitis Pigmentosa (Extension of Study RET IRD 01)

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2012-01-01
  • Closing Date: 2014-05-01

Criteria

More information

Children: Yes

Adults: Yes

Funder Type: private

HCP: Principal investigators

HCP: Other investigators

Within ERN-EYE members

Principal investigators



Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe

* indicates required

This ERN is supported by: